|
|
|
|
|
|
|
|
Open access
In conclusion, Strategy 1 (IHC test followed by BRAF test) evaluated in our study has been found to be cost-effective relative to the Referent strategy. This is the first cost-effectiveness analysis for evaluating different genetic testing strategies for LS in Taiwan. As such, the results will be informative for the NHI when considering offering screening for LS in patients newly diagnosed with CRC.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.